← Eichor
Study identifier: NCT06205342 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

Condition: Chronic Pancreatitis · Chronic Pain  ·  Sponsor: Medical University of South Carolina

PhaseEARLY_Phase 1
Planned participants48
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This protocol aims to test whether an infusion of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) can reduce pain associated with chronic pancreatitis (CP) and explore potential mechanisms of MSC action.

This description comes directly from the study's public registry record.

Talk to the study team

Leah Benn, MPH  ·  843-792-2813  ·  bennle@musc.edu

Bridger Scoggins  ·  (843) 792-6388  ·  scoggibr@musc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University of South CarolinaCharleston, South Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06205342